Journal of Diabetes and Its Complications
Volume 17, Issue 1 , Pages 22-26 , January 2003

The mechanisms of inhibitory actions of gliclazide on neutrophils–endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration

Received 18 September 2001 ,Revised 24 October 2001 ,Accepted 29 October 2001.

References 

  1. Akanuma Y, Kosaka K, Kanazawa Y, Kasuga M, Fukuda M, Aoki S. Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas. Diabetes Research and Clinical Practice. 1988;5:81–90
  2. Chiasson JL, Hamet P, Verdy M. The effect of Diamicron on the secretion and action of insulin. Diabetes Research and Clinical Practice. 1991;14:S47–S52
  3. Desfaits AC, Serri O, Renier G. Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism. 1997;46:1150–1156
  4. Fukuzawa M, Satoh J, Qiang X, Miyaguchi S, Sakata Y, Nakazawa T, et al. Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diabetes Research and Clinical Practice. 1999;43:147–154
  5. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974;23:105–111
  6. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte–endothelial cell adhesion. Journal of Leukocyte Biology. 1994;55:662–675
  7. Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte involvement during ischemia and perfusion of intestine. Methods in Enzymology. 1990;186:729–742
  8. Hu S, Wang S, Dunning BE. Tissue selectivity of antidiabetic agent, nategulinide: study on cardiovascular and beta-cell KATP channels. Journal of Pharmacology and Experimental Therapy. 1999;291:1372–1379
  9. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126
  10. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. Journal of Clinical Investigation. 1995;95:1262–1270
  11. Lawrence MB, McIntire LV, Eskin SG. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood. 1987;70:1284–1290
  12. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859–873
  13. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541–554
  14. Noda Y, Mori A, Packer L. Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Research Communications in Molecular Pathology and Pharmacology. 1997;96:115–124
  15. Obata T, Yamanaka Y. Glibenclamide, an antagonist of ATP sensitive K+ channels blocks free radical generation in the rat myocardium. Neuroscience Letters. 1998;257:57–59
  16. Okayama N, Coe L, Oshima T, Itoh M, Alexander JS. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells. Microvascular Research. 1999;57:63–74
  17. Okayama N, Ichikawa H, Coe L, Itoh M, Alexander JS. Exogenous NO enhances hydrogen peroxide-mediated neutrophil adherence to cultured endothelial cells. American Journal of Physiology. 1998;274:820–826
  18. Omi, H., Okayama, N., Shimizu, M., Okouchi, M., Ito, S., Fukutomi, T., & Itoh, M. (in press). Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effects of antidiabetic medicines. Journal of Diabetes and its Complications.
  19. Palmer KJ, Brogden RN. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin dependent diabetes mellitus. Drugs. 1993;46:92–125
  20. Qiang X, Satoh J, Sagara M, Fukuzawa M, Masuda T, Miyaguchi S, et al. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metabolism. 1998;47:977–981
  21. Ridker PM. High-sensitivity c-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  22. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of c-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–733
  23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine. 1997;336:973–979
  24. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-creative protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425–428
  25. Ruoslahti E. Integrins. Journal of Clinical Investigation. 1991;87:1–5
  26. Scott NA, Jennings PE, Brown J, Belch JJ. Gliclazide: a general free radical scavenger. European Journal of Pharmacology. 1991;208:175–177
  27. Scwanstecher M, Mnner K, Panten U. Inhibition of K+ channel and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets. Pharmacology. 1994;49:105–111
  28. Suzuki N, Svensson K, Eriksson UJ. High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia. 1996;39:401–411
  29. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986

PII: S1056-8727(01)00219-7

Journal of Diabetes and Its Complications
Volume 17, Issue 1 , Pages 22-26 , January 2003

Article Tools

* Image Usage & Resolution